Skip to main content
Erschienen in: Journal of Cancer Survivorship 2/2014

01.06.2014

Occurrence of comorbidities among African-American and Latina breast cancer survivors

verfasst von: Kimlin Ashing, Monica Rosales, Lily Lai, Arti Hurria

Erschienen in: Journal of Cancer Survivorship | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

The co-occurrence of multiple chronic conditions in cancer patients is common and can have negative impact on cancer and cancer survivorship outcomes. This study aimed to document comorbidity occurrence among African-American and Latina (English language preferred (ELP) and Spanish language preferred (SLP)) breast cancer survivors (BCS).

Methods

Eighty-eight African-American, 95 ELP Latina, and 137 SLP Latina BCS were recruited via case ascertainment from the California Cancer Registry and hospital registries. BCS completed a self-report questionnaire assessing demographic and cancer characteristics, and presence of comorbidities.

Results

Overall, 75 % of BCS reported at least one comorbidity with arthritis (37 %), high blood pressure (37 %), psychological difficulties (29 %), and diabetes (19 %) being most commonly endorsed. SLP Latinas were more likely to report diabetes (29 %), psychological difficulties (42 %), and >3 comorbidities (p < 0.05). Latina BCS were twice as likely to report osteoporosis and headaches compared to African-Americans; while one in two African-Americans reported hypertension and arthritis. Older age was correlated with arthritis, diabetes, glaucoma, high blood pressure, and osteoporosis.

Conclusions

Our findings suggest that investigating the occurrence of comorbidities across ethnic groups may shed some light in understanding cancer survivorship risk for poor health outcomes and health disparities. Having a better grasp of comorbid conditions may aid in more appropriate early assessment, better follow-up care, surveillance, and management of the cancer and the comorbid condition(s).

Implications for Cancer Survivors

Integrated control and management of comorbidities among cancer survivors has the potential to improve quality care for the whole person, and increase survival and decrease morbidity.
Literatur
1.
Zurück zum Zitat Land LH et al. Comorbidity and survival after early breast cancer: a review. Crit Rev Oncol/Hematol. 2012;81:196–205.CrossRef Land LH et al. Comorbidity and survival after early breast cancer: a review. Crit Rev Oncol/Hematol. 2012;81:196–205.CrossRef
2.
Zurück zum Zitat Koroukian SM, Murray P, Madigan E. Comorbidity, disability, and geriatric syndromes in elderly cancer patients receiving home health care. JCO. 2006;24(15):2304–10.CrossRef Koroukian SM, Murray P, Madigan E. Comorbidity, disability, and geriatric syndromes in elderly cancer patients receiving home health care. JCO. 2006;24(15):2304–10.CrossRef
3.
Zurück zum Zitat Ogle KS et al. Cancer and comorbidity: redefining chronic diseases. Cancer. 2000;88:653–63.CrossRefPubMed Ogle KS et al. Cancer and comorbidity: redefining chronic diseases. Cancer. 2000;88:653–63.CrossRefPubMed
4.
Zurück zum Zitat Smith AW et al. Cancer, comorbidities, and health related quality of life of older adults. Health Care Financ Rev. 2008;29(4):41–56.PubMedCentralPubMed Smith AW et al. Cancer, comorbidities, and health related quality of life of older adults. Health Care Financ Rev. 2008;29(4):41–56.PubMedCentralPubMed
5.
Zurück zum Zitat Barone B et al. Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis. Diabetes Care. 2010;33(4):931–9.PubMedCentralCrossRefPubMed Barone B et al. Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis. Diabetes Care. 2010;33(4):931–9.PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Kumar S, Hurria A. Impact of age, sex, and comorbidity on cancer therapy and disease progression. JCO. 2010;28(26):4086–93.CrossRef Kumar S, Hurria A. Impact of age, sex, and comorbidity on cancer therapy and disease progression. JCO. 2010;28(26):4086–93.CrossRef
7.
Zurück zum Zitat Yancik R et al. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 and older. JAMA. 2001;285(7):885–92.CrossRefPubMed Yancik R et al. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 and older. JAMA. 2001;285(7):885–92.CrossRefPubMed
8.
Zurück zum Zitat Hershey DS et al. Perceived impact of cancer treatment on diabetes self-management. Diabetes Educ. 2012;38(6):779–90.CrossRefPubMed Hershey DS et al. Perceived impact of cancer treatment on diabetes self-management. Diabetes Educ. 2012;38(6):779–90.CrossRefPubMed
9.
Zurück zum Zitat Berglund A et al. Impact of comorbidity on management and mortality in women diagnosed with breast cancer. Breast Cancer Res Treat. 2012;135:281–9.CrossRefPubMed Berglund A et al. Impact of comorbidity on management and mortality in women diagnosed with breast cancer. Breast Cancer Res Treat. 2012;135:281–9.CrossRefPubMed
10.
Zurück zum Zitat Cronin-Fenton DP et al. Comorbidity and survival of Danish breast cancer patients from 1995-2005. Br J Cancer. 2007;96:1462–8.PubMedCentralPubMed Cronin-Fenton DP et al. Comorbidity and survival of Danish breast cancer patients from 1995-2005. Br J Cancer. 2007;96:1462–8.PubMedCentralPubMed
11.
Zurück zum Zitat Patnaik JL et al. The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst. 2011;103(14):1101–11.PubMedCentralCrossRefPubMed Patnaik JL et al. The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst. 2011;103(14):1101–11.PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Peairs K et al. Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. JCO. 2011;29:40–6.CrossRef Peairs K et al. Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. JCO. 2011;29:40–6.CrossRef
13.
Zurück zum Zitat Polednak AP, Phillips CE. Obtaining data on comorbid diabetes among patients in a US population-based tumor registry. J Registry Manag. 2010;37(2):57–64.PubMed Polednak AP, Phillips CE. Obtaining data on comorbid diabetes among patients in a US population-based tumor registry. J Registry Manag. 2010;37(2):57–64.PubMed
14.
Zurück zum Zitat Smith MR. Treatment-related diabetes and cardiovascular disease in prostate cancer survivors. Ann Oncol. 2008;19(Supp 7):vii86–90.PubMedCentralPubMed Smith MR. Treatment-related diabetes and cardiovascular disease in prostate cancer survivors. Ann Oncol. 2008;19(Supp 7):vii86–90.PubMedCentralPubMed
16.
Zurück zum Zitat Braithwaite D et al. Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomark Prev. 2012;21(7):1115–25.CrossRef Braithwaite D et al. Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomark Prev. 2012;21(7):1115–25.CrossRef
17.
Zurück zum Zitat Tammemagi CM. Racial/ethnic disparities in breast and gynecologic cancer treatment and outcomes. Curr Opin Obstet Gynecol. 2007;19(1):31–6.CrossRefPubMed Tammemagi CM. Racial/ethnic disparities in breast and gynecologic cancer treatment and outcomes. Curr Opin Obstet Gynecol. 2007;19(1):31–6.CrossRefPubMed
18.
Zurück zum Zitat Tammemagi CM et al. Comorbidity and survival disparities among Black and White patients with breast cancer. JAMA. 2005;294(14):1765–72.CrossRefPubMed Tammemagi CM et al. Comorbidity and survival disparities among Black and White patients with breast cancer. JAMA. 2005;294(14):1765–72.CrossRefPubMed
19.
Zurück zum Zitat Louwman WJ et al. Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer. 2005;41(5):779–85.CrossRefPubMed Louwman WJ et al. Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer. 2005;41(5):779–85.CrossRefPubMed
20.
Zurück zum Zitat Du XL, Fang S, Meyer T. Impact of treatment and socioeconomic status on racial disparities in survival among older women with breast cancer. Am J Clin Oncol. 2008;31(2):125–32.CrossRefPubMed Du XL, Fang S, Meyer T. Impact of treatment and socioeconomic status on racial disparities in survival among older women with breast cancer. Am J Clin Oncol. 2008;31(2):125–32.CrossRefPubMed
21.
Zurück zum Zitat Ashing-Giwa K, Ganz PA, Petersen L. Quality of life of African-American and White long-term breast cancer survivors. Cancer. 1999;85(2):418–26.CrossRefPubMed Ashing-Giwa K, Ganz PA, Petersen L. Quality of life of African-American and White long-term breast cancer survivors. Cancer. 1999;85(2):418–26.CrossRefPubMed
22.
23.
Zurück zum Zitat Extermann M. Measuring comorbidity in older cancer patients. Eur J Cancer. 2000;36(4):453–71.CrossRefPubMed Extermann M. Measuring comorbidity in older cancer patients. Eur J Cancer. 2000;36(4):453–71.CrossRefPubMed
24.
Zurück zum Zitat Fleming ST et al. A comprehensive prognostic index to predict survival based on multiple comorbidities: a focus on breast cancer. Med Care. 1999;37(6):601–14.CrossRefPubMed Fleming ST et al. A comprehensive prognostic index to predict survival based on multiple comorbidities: a focus on breast cancer. Med Care. 1999;37(6):601–14.CrossRefPubMed
25.
Zurück zum Zitat Ashing-Giwa K, Rosales M. A cross-cultural validation of patient-reported outcome measures: a study of breast cancers survivors. Qual Life Res. 2013;22:295–308.CrossRefPubMed Ashing-Giwa K, Rosales M. A cross-cultural validation of patient-reported outcome measures: a study of breast cancers survivors. Qual Life Res. 2013;22:295–308.CrossRefPubMed
26.
Zurück zum Zitat Ashing-Giwa K et al. Depressive symptomatology among Latina breast cancer survivors. 2013;22:845–53. Ashing-Giwa K et al. Depressive symptomatology among Latina breast cancer survivors. 2013;22:845–53.
27.
Zurück zum Zitat Janz NK et al. Racial/ethnic differences in quality of life after diagnosis of breast cancer. J Cancer Surviv. 2009;3:212–22.CrossRefPubMed Janz NK et al. Racial/ethnic differences in quality of life after diagnosis of breast cancer. J Cancer Surviv. 2009;3:212–22.CrossRefPubMed
28.
Zurück zum Zitat Lopez ME et al. Ductal carcinoma in situ (DCIS): posttreatment follow-up care among Latina and non-Latina white women. J Caner Surviv. 2013;7(2):219–26.CrossRef Lopez ME et al. Ductal carcinoma in situ (DCIS): posttreatment follow-up care among Latina and non-Latina white women. J Caner Surviv. 2013;7(2):219–26.CrossRef
29.
Zurück zum Zitat Napoles AM et al. Interpersonal processes of care and patient satisfaction: do associations differ by race, ethnicity, and language? Health Serv Res. 2009;44(4):1326–44.PubMedCentralCrossRefPubMed Napoles AM et al. Interpersonal processes of care and patient satisfaction: do associations differ by race, ethnicity, and language? Health Serv Res. 2009;44(4):1326–44.PubMedCentralCrossRefPubMed
30.
Zurück zum Zitat Ashing K, Rosales M (2013) A telephonic-based trial to reduce depressive symptoms among Latina breast cancer survivors. Psychooncology (in press) Ashing K, Rosales M (2013) A telephonic-based trial to reduce depressive symptoms among Latina breast cancer survivors. Psychooncology (in press)
31.
Zurück zum Zitat Ashing-Giwa K et al. Breast cancer survivorship in a multiethnic sample: challenges in recruitment and measurement. Cancer. 2004;101(3):450–65.CrossRefPubMed Ashing-Giwa K et al. Breast cancer survivorship in a multiethnic sample: challenges in recruitment and measurement. Cancer. 2004;101(3):450–65.CrossRefPubMed
32.
Zurück zum Zitat Ashing-Giwa K et al. Examining predictive models of HRQOL in a population-based, multiethnic sample of women with breast carcinoma. Qual Life Res. 2007;16(3):413–28.CrossRefPubMed Ashing-Giwa K et al. Examining predictive models of HRQOL in a population-based, multiethnic sample of women with breast carcinoma. Qual Life Res. 2007;16(3):413–28.CrossRefPubMed
33.
34.
Zurück zum Zitat Hurria A, Mohile S, Dale W. Research priorities in geriatric oncology: addressing the needs of an aging population. J Natl Compr Cancer Netw. 2012;10(2):286–8. Hurria A, Mohile S, Dale W. Research priorities in geriatric oncology: addressing the needs of an aging population. J Natl Compr Cancer Netw. 2012;10(2):286–8.
35.
Zurück zum Zitat Ring A, Sestak I, Baum M. Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen Alone or in combination trial. J Clin Oncol. 2011;29(32):4266–72.CrossRefPubMed Ring A, Sestak I, Baum M. Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen Alone or in combination trial. J Clin Oncol. 2011;29(32):4266–72.CrossRefPubMed
36.
Zurück zum Zitat Dwight-Johnson M, Ell K, Lee P-J. Can collaborative care address the needs of low-income Latinas with comorbid depression and cancer? Results from a randomized pilot study. Psychosom. 2005;46(3):224–32.CrossRef Dwight-Johnson M, Ell K, Lee P-J. Can collaborative care address the needs of low-income Latinas with comorbid depression and cancer? Results from a randomized pilot study. Psychosom. 2005;46(3):224–32.CrossRef
37.
Zurück zum Zitat Buki LP et al. Latina breast cancer survivors’ lived experiences: diagnosis, treatment, and beyond. Cult Divers Ethn Minor Psychol. 2008;14(2):163–7.CrossRef Buki LP et al. Latina breast cancer survivors’ lived experiences: diagnosis, treatment, and beyond. Cult Divers Ethn Minor Psychol. 2008;14(2):163–7.CrossRef
38.
Zurück zum Zitat Ell K et al. Improving treatment of depression among low-income patients with cancer: the design of the ADAPt-C study. Gen Hosp Psychiatry. 2007;29:223–31.PubMedCentralCrossRefPubMed Ell K et al. Improving treatment of depression among low-income patients with cancer: the design of the ADAPt-C study. Gen Hosp Psychiatry. 2007;29:223–31.PubMedCentralCrossRefPubMed
39.
Zurück zum Zitat Ell K et al. Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer. J Clin Oncol. 2005;23(13):3052–60.PubMedCentralCrossRefPubMed Ell K et al. Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer. J Clin Oncol. 2005;23(13):3052–60.PubMedCentralCrossRefPubMed
40.
Zurück zum Zitat Eversley R et al. Post-treatment symptoms among ethnic minority breast cancer survivors. Oncol Nurs Forum. 2005;32(2):250–5.CrossRefPubMed Eversley R et al. Post-treatment symptoms among ethnic minority breast cancer survivors. Oncol Nurs Forum. 2005;32(2):250–5.CrossRefPubMed
41.
Zurück zum Zitat Eley JW et al. Racial differences in survival from breast cancer: results of the National Cancer Institute Black/White cancer survival study. JAMA. 1994;272:947–54.CrossRefPubMed Eley JW et al. Racial differences in survival from breast cancer: results of the National Cancer Institute Black/White cancer survival study. JAMA. 1994;272:947–54.CrossRefPubMed
42.
Zurück zum Zitat Ashing-Giwa K, Rosales M. Recruitment and retention strategies of African American and Latina American breast cancer survivors in a longitudinal psycho-oncology study. Oncol Nurs Forum. 2012;39(5):E434–42.CrossRefPubMed Ashing-Giwa K, Rosales M. Recruitment and retention strategies of African American and Latina American breast cancer survivors in a longitudinal psycho-oncology study. Oncol Nurs Forum. 2012;39(5):E434–42.CrossRefPubMed
43.
Zurück zum Zitat Parsons HM et al. What happens to racial and ethnic minorities after cancer surgery at American College of Surgeons national surgical quality improvement program hospitals? J Am Coll Sug. 2012;214(4):539–49.CrossRef Parsons HM et al. What happens to racial and ethnic minorities after cancer surgery at American College of Surgeons national surgical quality improvement program hospitals? J Am Coll Sug. 2012;214(4):539–49.CrossRef
44.
Zurück zum Zitat Weaver KE et al. Forgoing medical care because of cost: assessing disparities in health care access among cancer survivors living in the United States. Cancer. 2010;116(14):3493–504.PubMedCentralCrossRefPubMed Weaver KE et al. Forgoing medical care because of cost: assessing disparities in health care access among cancer survivors living in the United States. Cancer. 2010;116(14):3493–504.PubMedCentralCrossRefPubMed
45.
Zurück zum Zitat Galvan N, Buki LP, Garces DM. Suddenly, a carriage appears: social support needs of Latina breast cancer survivors. J Psychosoc Oncol. 2009;27(3):361–82.CrossRefPubMed Galvan N, Buki LP, Garces DM. Suddenly, a carriage appears: social support needs of Latina breast cancer survivors. J Psychosoc Oncol. 2009;27(3):361–82.CrossRefPubMed
Metadaten
Titel
Occurrence of comorbidities among African-American and Latina breast cancer survivors
verfasst von
Kimlin Ashing
Monica Rosales
Lily Lai
Arti Hurria
Publikationsdatum
01.06.2014
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 2/2014
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-014-0342-x

Weitere Artikel der Ausgabe 2/2014

Journal of Cancer Survivorship 2/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.